• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特发性肺动脉高压患者的缺铁问题。

Iron deficiency in patients with idiopathic pulmonary arterial hypertension.

机构信息

Baker IDI Heart and Diabetes Institute, Melbourne, Australia; Heart Center, Alfred Hospital, Melbourne, Australia.

Allergy, Immunology and Respiratory Medicine, Alfred Hospital, Melbourne, Australia.

出版信息

Heart Lung Circ. 2014 Mar;23(3):287-92. doi: 10.1016/j.hlc.2013.08.007. Epub 2013 Sep 1.

DOI:10.1016/j.hlc.2013.08.007
PMID:24094431
Abstract

BACKGROUND

Iron deficiency has been reported to be highly prevalent in idiopathic pulmonary arterial hypertension (iPAH) patients, with the potential to influence cardiac performance, pulmonary artery pressures and the pulmonary vascular response to hypoxia.

METHODS

Iron status was evaluated in 29 iPAH patients, and was related to haemodynamic, echocardiographic and exercise parameters.

RESULTS

Iron deficiency was present in 44.8% of all iPAH patients, although anaemia was only present in 13.8%. Iron-deficient patients had similar exercise capacity (6MWD: 446±141 m), compared to iron-sufficient patients (421±193 m), however 46.2% of iron deficient patients had NYHA FC 3 or higher, compared to 12.5% in non-iron deficient group. Additionally iron-deficient patients showed increased mean pulmonary arterial pressure (63.3±12.2 mmHg; iron deficient vs. 38.8±16.7 mmHg; non-iron deficient) and reduced cardiac index (1.3±0.2 L/min/m(2); iron deficient vs. 2.5±0.4 L/min/m(2); non-iron deficient).

CONCLUSIONS

Iron deficiency is highly prevalent in iPAH, and the extent of iron deficiency is related to haemodynamics and NYHA functional class. While the exact mechanism of iron deficiency is unknown, our study suggests that treatment of iron deficiency should be considered in iPAH patients.

摘要

背景

缺铁症在特发性肺动脉高压(iPAH)患者中较为常见,可能会影响心脏功能、肺动脉压力和肺血管对缺氧的反应。

方法

评估了 29 例 iPAH 患者的铁状态,并将其与血流动力学、超声心动图和运动参数相关联。

结果

所有 iPAH 患者中有 44.8%存在缺铁症,尽管只有 13.8%存在贫血。缺铁症患者的运动能力(6MWD:446±141m)与铁充足患者相似(421±193m),然而,46.2%的缺铁症患者的 NYHA FC 为 3 或更高,而非缺铁症组中仅为 12.5%。此外,缺铁症患者的平均肺动脉压(63.3±12.2mmHg;缺铁症患者 vs. 38.8±16.7mmHg;非缺铁症患者)更高,心指数(1.3±0.2L/min/m2;缺铁症患者 vs. 2.5±0.4L/min/m2;非缺铁症患者)更低。

结论

缺铁症在 iPAH 中较为常见,缺铁症的严重程度与血流动力学和 NYHA 功能分级相关。尽管缺铁症的确切机制尚不清楚,但我们的研究表明,应考虑对 iPAH 患者进行缺铁症治疗。

相似文献

1
Iron deficiency in patients with idiopathic pulmonary arterial hypertension.特发性肺动脉高压患者的缺铁问题。
Heart Lung Circ. 2014 Mar;23(3):287-92. doi: 10.1016/j.hlc.2013.08.007. Epub 2013 Sep 1.
2
Iron deficiency is common in idiopathic pulmonary arterial hypertension.特发性肺动脉高压患者常伴有缺铁。
Eur Respir J. 2011 Jun;37(6):1386-91. doi: 10.1183/09031936.00100510. Epub 2010 Sep 30.
3
L-arginine plasma levels and severity of idiopathic pulmonary arterial hypertension.
Vasa. 2008 Feb;37(1):61-7. doi: 10.1024/0301-1526.37.1.61.
4
Changes in exercise haemodynamics during treatment in pulmonary arterial hypertension.肺动脉高压治疗期间运动血流动力学的变化。
Eur Respir J. 2008 Aug;32(2):393-8. doi: 10.1183/09031936.00009008. Epub 2008 Apr 16.
5
[Clinical observation of cardiopulmonary exercise test in patients with idiopathic pulmonary arterial hypertension].[特发性肺动脉高压患者心肺运动试验的临床观察]
Zhonghua Yi Xue Za Zhi. 2013 Jun 11;93(22):1683-6.
6
Pulmonary capillary endothelial metabolic dysfunction: severity in pulmonary arterial hypertension related to connective tissue disease versus idiopathic pulmonary arterial hypertension.肺毛细血管内皮代谢功能障碍:与结缔组织病相关的肺动脉高压与特发性肺动脉高压的严重程度比较
Arthritis Rheum. 2008 Apr;58(4):1156-64. doi: 10.1002/art.23405.
7
[Clinical analysis of 150 patients with idiopathic pulmonary arterial hypertension].
Zhonghua Xin Xue Guan Bing Za Zhi. 2012 Aug;40(8):657-61.
8
Survival in schistosomiasis-associated pulmonary arterial hypertension.血吸虫病相关肺动脉高压的生存情况。
J Am Coll Cardiol. 2010 Aug 24;56(9):715-20. doi: 10.1016/j.jacc.2010.03.065.
9
Severely reduced diffusion capacity in idiopathic pulmonary arterial hypertension: patient characteristics and treatment responses.特发性肺动脉高压患者的弥散能力严重降低:患者特征和治疗反应。
Eur Respir J. 2013 Dec;42(6):1575-85. doi: 10.1183/09031936.00184412. Epub 2013 Aug 15.
10
Addition of sildenafil to bosentan monotherapy in pulmonary arterial hypertension.在肺动脉高压患者中,西地那非联合波生坦单药治疗。
Eur Respir J. 2007 Mar;29(3):469-75. doi: 10.1183/09031936.00081706. Epub 2006 Nov 1.

引用本文的文献

1
Hepcidin and Tissue-Specific Iron Regulatory Networks.铁调素与组织特异性铁调节网络
Adv Exp Med Biol. 2025;1480:89-102. doi: 10.1007/978-3-031-92033-2_7.
2
Immature reticulocyte fraction: A novel biomarker of hemodynamic severity in pulmonary arterial hypertension.未成熟网织红细胞比例:肺动脉高压血流动力学严重程度的一种新型生物标志物。
Pulm Circ. 2024 Aug 5;14(3):e12421. doi: 10.1002/pul2.12421. eCollection 2024 Jul.
3
Iron Deficiency in Heart Failure and Pulmonary Hypertension.心力衰竭和肺动脉高压中的缺铁
Curr Treat Options Cardiovasc Med. 2022 Dec;24(12):213-229. doi: 10.1007/s11936-022-00971-4. Epub 2022 Oct 4.
4
Iron deficiency and supplementation in heart failure.心力衰竭中的铁缺乏与补充。
Nat Rev Cardiol. 2024 Jul;21(7):463-486. doi: 10.1038/s41569-024-00988-1. Epub 2024 Feb 7.
5
Iron deficiency in pulmonary vascular disease: pathophysiological and clinical implications.肺血管疾病中的铁缺乏:病理生理学及临床意义
Eur Heart J. 2023 Jun 9;44(22):1979-1991. doi: 10.1093/eurheartj/ehad149.
6
Bmpr2 mutant mice are an inadequate model for studying iron deficiency in pulmonary hypertension.Bmpr2突变小鼠并非用于研究肺动脉高压中铁缺乏的理想模型。
Pulm Circ. 2022 Oct 1;12(4):e12151. doi: 10.1002/pul2.12151. eCollection 2022 Oct.
7
Iron deficiency and cardiovascular disease.缺铁与心血管疾病。
Eur Heart J. 2023 Jan 1;44(1):14-27. doi: 10.1093/eurheartj/ehac569.
8
Cigarette Smoke Particle-Induced Lung Injury and Iron Homeostasis.香烟烟雾颗粒诱导的肺损伤与铁稳态
Int J Chron Obstruct Pulmon Dis. 2022 Jan 12;17:117-140. doi: 10.2147/COPD.S337354. eCollection 2022.
9
Novel Experimental Therapies for Treatment of Pulmonary Arterial Hypertension.治疗肺动脉高压的新型实验性疗法
J Exp Pharmacol. 2021 Aug 17;13:817-857. doi: 10.2147/JEP.S236743. eCollection 2021.
10
Iron Deficiency Is Associated With More Severe Pulmonary Vascular Disease in Pulmonary Hypertension Caused by Chronic Lung Disease.缺铁与慢性肺病所致肺动脉高压中更严重的肺血管疾病相关。
Chest. 2022 Jan;161(1):232-236. doi: 10.1016/j.chest.2021.07.2159. Epub 2021 Aug 2.